Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer
出版年份 2013 全文链接
标题
Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer
作者
关键词
NLR, CEA, Colorectal cancer, Biomarker, Prognosis
出版物
MEDICAL ONCOLOGY
Volume 30, Issue 1, Pages -
出版商
Springer Nature
发表日期
2013-01-10
DOI
10.1007/s12032-012-0439-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Inflammatory Markers in Blood and Serum Tumor Markers Predict Survival in Patients With Epithelial Appendiceal Neoplasms Undergoing Surgical Cytoreduction and Intraperitoneal Chemotherapy
- (2012) Terence C. Chua et al. ANNALS OF SURGERY
- Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer
- (2012) Hyuk-Chan Kwon et al. BIOMARKERS
- Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer
- (2012) R. Carruthers et al. Colorectal Disease
- Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively?
- (2012) Sum-Fu Chiang et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
- (2011) W Chua et al. BRITISH JOURNAL OF CANCER
- An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
- (2011) M J Proctor et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy
- (2011) A. Zaanan et al. CLINICAL CANCER RESEARCH
- Association of Obesity With DNA Mismatch Repair Status and Clinical Outcome in Patients With Stage II or III Colon Carcinoma Participating in NCCTG and NSABP Adjuvant Chemotherapy Trials
- (2011) Frank A. Sinicrope et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA methylation predicts recurrence from resected stage III proximal colon cancer
- (2010) Joong Bae Ahn et al. CANCER
- IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis
- (2009) Dawei Li et al. ANNALS OF SURGICAL ONCOLOGY
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
- (2009) Campbell SD Roxburgh et al. Future Oncology
- PIK3CAMutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer
- (2009) Shuji Ogino et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy
- (2009) Andrea Koch et al. Journal of Thoracic Oncology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started